Medical Management of Erectile Dysfunction. Maarten Albersen MD PhD University Hospitals Leuven,
|
|
- Elwin Wright
- 5 years ago
- Views:
Transcription
1 Medical Management of Erectile Dysfunction Maarten Albersen MD PhD University Hospitals Leuven,
2 COI Consultancy/speaker for: Ferring, Sanofi, BSCI, Coloplast, Pfizer, Lilly, Menarini, Berlin-Chemie
3 1. Aytaç IA, et al. BJU International 1999;84: Vlachopoulos C V, et al. Circ Cardiovasc Qual Outcomes 2013;6: Fan Yet al. World J Urol Erectile Dysfunction Is the inability to develop and maintain an erection for satisfactory sexual intercourse or activity. < Age 1 Endocrine Vascular Neurogenic Psychogenic Drugs & abuse Mixed Cardiovascular events 2 All cause mortality 3
4 Erectile dysfunction: BURDEN Negative consequences for sexual experience and emotional wellbeing 1 Unsatisfactory sexual life 2 frustration and lack of spontaneity Affected emotional well being 1 concern over severe ongoing pathologies (cardiovascular disease, hypertension, diabetes, consequences of prostatectomy) 2 Can cause embarrassment, hindering communication, 3 and create concerns for both patients and partners 4, with reduced quality of life 2 1. Becher Cuzin 2016; 3. Hedon 2003 (figure) 4. DiMeo 2006
5 Diagnostic Work-up Patient with ED (self-reported) Medical and psychosexual history (use of validated instruments, e.g. IIEF) Identify other than ED sexual problems Identify common causes of ED Identify reversible risk factors for ED Assess psychosocial status Focused physical examination Penile deformities Prostatic disease Signs of hypogonadism Cardiovascular and neurological status Laboratory tests Glucose-lipid profile (if not assessed in the last 12 months) Total testosterone (morning sample) if indicated, bio-available or free testosterone Algorythm derived from EAU guidelines
6 Diagnostic Work-up: IIEF-EF How often were you able to get an erection during sexual activity? When you had erections with sexual stimulation, how often were your erections hard enough for penetration? During sexual intercourse, how often were you able to maintain your erection after you had penetrated (entered) your partner? During sexual intercourse, how difficult was it to maintain your erection to completion of intercourse? When you attempted sexual intercourse, how often was it satisfactory for you? How do you rate your confidence that you could get and keep an erection? Range 6-30 points, MCID = 4 points SEP 2 (%) SEP 3 (%)
7 Medical Management EAU GL
8 Medical Management Lifestyle Pharmacotherapy PDE5i Testosterone Alprostadil (and injectables) Shockwave therapy (Surgical therapy)
9 Lifestyle (association) There is a wealth in evidence on association of lifestyle factors and risk of ED: Smoking: adjusted odds ratio: 1.43 ( ) Becomes apparent after 20 PY Alcohol intake: 0.93 ( ) Physical excercise: 0.68 ( ) Diet: 0.93 ( ) (NS, unadjusted significant) Allen et al. JSM 2018
10 Lifestyle (intervention) Diet: DM2 patients allocated to meditteranean vs low-fat diet had less decrease of IIEF-scores over 8 year period (difference 1.22 points) 1 Exercise: addition of a prespecified exercise program to standard treatment (PDE5i) results in less ED following myocardial infarction 2, and a 2 point increase in IIEF-EF 3 Weight loss in overweight/obese (exercise & diet): 3 RCTs: +1.4 (IIEF-5) (IIEF-EF) (IIEF-EF) 6 OSAS: Addition of PEEP therapy to standard treatment for ED results in improved erectile function and increased PDE5i response 7 Smoking cessation: 25% of ex-smokers and no persistent smokers noted improvement in erectile function. 8 Effect not observed in severe ED. Effect size not reported. Thus: lifestyle modifications are recommended, but effect size is very small However: poor complicance is an issue (exercise 47%, diet 15-24%) 8 1. Maiorino et al. J. Diab. Compl Begot et al. Am J Cardiol Maio et al. JSM Collins et al. Obes Res Clin Pract Wing et al. JSM Moran et al. Plos One Campos-Juanatey, Asian J Androl Plourmand et al. BJUI Mulhall JSM 2018
11 Phosphodiesterase 5 - inhibitors Phosphodiesterase type 5 (PDE5) inhibitors are effective, safe, and welltolerated therapies for the treatment of men with ED (level of evidence = 1; grade of recommendation = A). PDE5 inhibitors are first-line therapy for most men with ED who do not have a specific contraindication to their use (level of evidence = 3; grade of recommendation = C). There are no significant differences in efficacy, safety, and tolerability among PDE5 inhibitors (level of evidence = 1; grade of recommendation = A). Dose titration of PDE5 inhibitors to the maximum tolerated dose is strongly recommended because it increases efficacy and satisfaction from treatment (level of Sexual stimulus needed! ICSM Hatzimouratidis K. JSM 2016
12 PDE5i PRN: pharmacokinetics
13 PDE5i PRN: adverse events Adverse event (%) Sildenafil Tadalafil Vardenafil Avanafil Headache Flushing Upper respiratory disorders Dyspepsia <1 Dizziness <1 Abnormal vision 2 <1 <2 <1 Back pain 7 <1 <1 Myalgia <1 6 <1 Penile pain/burning Genital/testicular pain Urethral burning/bleeding/spotting Penile erythema/infection Injection site reactions Penis disorder Prolonged erection Penile rash/oedema
14 Comparative efficacy/tolerability No randomized controlled trial has directly compared all currently available PDE5Is. Outcome measures differ between studies (IIEF- EF, GAQ-1, SEP2, SEP3) No hard conclusions can be reached. Network meta-analysis gives clues: tolerability differs, efficacy overlapping CIs. Chen et al. Eur Urol 2015
15 PDE5i PRN: efficacy Forest plot of overall efficacy (from 82 trials, patients) for phosphodiesterase 5 inhibitors at different dosages. Chen et al. Eur Urol 2015
16 PDE5i PRN: adverse events Forest plot of any adverse event (from 72 trials, patients) for phosphodiesterase 5 inhibitors at different dosages. Chen et al. Eur Urol 2015
17 PDE5i OAD 400 Tadalafil plasma concentration (ng/ml) Time (hours) Brock et al. JSM 2016, Wrishko R et al. JSM 2009
18 My $0.02 on PDE5i Considerations in my personal practice (not EBM!): NO data are available provideing direct comparison between either of the four drugs in terms of efficacy or patient preference (one study on adherence: TAD better than SIL*) Patients get full info on all options Tadalafil PRN, OAD and Avanafil PRN have pharmacokinetic unique selling points IMO. Sildenafil and Vardenafil are short acting alternatives. *Buvat et al. JSM 2013
19 My $0.02 on PDE5i Don t want to take a pill when not needed Don t want to wait an hour/two before effects kick in / spontaneity Side effects on previous PDE5-i use >>> Avanafil 200 mg. 100 mg. 50 mg. Psychogenic predominance / performance anxiety Spontaneity Weekender/night out Comorbidity (LUTS, mainly) >>> Tadalafil 5 mg OAD (increasing interval over time), Tadalafil 20 mg PRN. Tadalafil 10 mg Short acting, effective and cheap although at the cost of adverse events: Sildenafil or Vardenafil
20 What if PDE5i don t work? 1.Jiann et al. Int J Impot Res 2006; 2.Carvalheira et al. J Sex Med 2012
21 Alprostadil Topical/intra-urethral/intracavernous Alprostadil camp production via adenylate cyclase via GCPR
22 Options for PDE5-i nonresponders? Alprostadil 300 μg produced statistically and clinically significant improvements in IIEF-EF scores ( 4 points), and positive GAQ responses, in patients with comorbidities (e.g. cardiac disease) and those with sildenafil failure N= 74, NNS RP IIEF-5: 18.1 SEP 2: 90% SEP 3: 78% Moncada & Cuzin 2015, Della Camera et al. Urologia 2015
23 PDE5i PRN: adverse events Adverse event (%) Sildenafil Tadalafil Vardenafil Avanafil Alprostadil (topical) Headache Flushing Upper respiratory disorders Dyspepsia <1 Dizziness <1 <1 Abnormal vision 2 <1 <2 <1 Back pain 7 <1 <1 Myalgia <1 6 <1 Penile pain/burning 23 Genital/testicular pain 18 Urethral burning/bleeding/spotting Penile erythema/infection 16 Injection site reactions Penis disorder 4 Prolonged erection Penile rash/oedema 1
24 Testosterone? Snyder, NEJM 2016
25 Testosterone? Effects on erectile function 1 PDE5i nonresponders 2 1.Corona et al. Eur Urol Corona et al. JSM 2014
26 Low-intensity Shockwave Rx
27 Low-intensity Shockwave Rx Fode et al. Nat Rev Urol 2017
28 Does it work: single-arm studies Consistent beneficial effects In spite of varying protocols In spite of varying devices used Benefits in the realm of 0-9 points on IIEF-EF score (MCID 4) Mostly short-term benefits
29 RCT data Author n Patients FU Rate EHS 3-4 IIEF-EF/5 change Risk of bias (mo) % (rate) vs sham Vardi et al. 40 Vasculogenic (56%) Low 2012 Olsen et al. 112 Vasculogenic (5 wk FU) NS Low (3 m FU) 19 (6 m FU) NS NS Yee et al. 58 Vasculogenic 1 NS Low 2014 Srini et al. 60 Vasculogenic High * 2015 Kitrey et al. 37 PDE5inonresponders (MCID 40.5%) Low 2016 Fojecki et al. 126 Vasculogenic NS Low NS Motil et al. 125 Vasculogenic (MCID 81.33%) High ** 2016 Kalyvianakis et al Vasculogenic (75%) Low Fojecki et al Vasuclogenic (NS) (NS) Low Power analysis: to detect MCID with baseline IIEF of 12: randomization of > 70!
30 Meta-analyses Meta-analysis Included studies IIEF-EF increase (sign in bold) Lu et al. 14 (7 RCT) 2.0 Clavijo et al. 7 RCT 4.17 Man et al Zou et al. 15 NR Angulo et al Inclusion of severly biased studies in meta-analysis Inclusion of studies on pelvic pain, peyronie s Double inclusion of positive data Either showing result < MCID, or not significant 1 Lu Z, et al: 2017 Eur Urol 2 Clavijo RI, et al: 2017 JSM 3 Man, L, et al: 2017 Urology 4 Zou Z, et al: 2017 Int Braz J Urol 5 Angulo JC, et al: 2017 Actas Urol Esp
31 Conclusions PDE5 inhibitors are the mainstay first line medical therapy. Efficacy comparable, different profiles for different patients Alternatives include alprostadil topical, intra-urethral or intracavernous, and penile implant. Testosterone has modest effects on erectile function. Low-intensity shockwave therapy has modest effects on erectile function, better studies are needed.
Is there a role for extracorporeal shock wave therapy for erectile dysfunction unresponsive to phosphodiesterase type 5 inhibitors?
DOI 10.1007/s00345-016-1899-y LETTER TO THE EDITOR Is there a role for extracorporeal shock wave therapy for erectile dysfunction unresponsive to phosphodiesterase type 5 inhibitors? Zi jun Zou 1 Zhi hong
More informationEAU GUIDELINES ON MALE SEXUAL DYSFUNCTION: Erectile Dysfunction and Premature Ejaculation
EAU GUIDELINES ON MALE SEXUAL DYSFUNCTION: Erectile Dysfunction and Premature Ejaculation (Partial text update March 2015) K. Hatzimouratidis (Chair), F. Giuliano, I. Moncada, A. Muneer, A. Salonia (Vice-chair),
More informationDaily vs. on-demand PDE-5 inhibitors for management of erectile dysfunction following treatment for prostate cancer
Daily vs. on-demand PDE-5 inhibitors for management of erectile dysfunction following treatment for prostate cancer Lead author: Nancy Kane Regional Drug & Therapeutics Centre (Newcastle) February 2018
More informationCanadian Undergraduate Urology Curriculum (CanUUC): Erectile Dysfunction
Canadian Undergraduate Urology Curriculum (CanUUC): Erectile Dysfunction Last reviewed July 2014 Objectives 1. Define erectile dysfunction 2. List and classify the risk factors for erectile dysfunction
More informationAbout Erectile Dysfunction. Causes, self-test and treatment
About Erectile Dysfunction Causes, self-test and treatment 2015 One Way S.r.l. All rights reserved. Gift copy for physicians. Illustrated by Davide Ceccon With an unrestricted grant from Recordati About
More information, David Stultz, MD. Erectile Dysfunction. David Stultz, MD September 10, 2001
Erectile Dysfunction David Stultz, MD September 10, 2001 Case Presentation A 66 year old male presents to your office requesting Viagra. He states that for the past year he has had difficulty forming
More informationIC351 (tadalafil, Cialis): update on clinical experience
(2002) 14, Suppl 1, S57 S64 ß 2002 Nature Publishing Group All rights reserved 0955-9930/02 $25.00 www.nature.com/ijir IC351 (tadalafil, Cialis): update on clinical experience 1 * 1 Urological practice,
More informationLow Energy Shockwaves for the Treatment of Erectile Dysfunction Y. Vardi, B. Appel, I Gruenwald
Low Energy Shockwaves for the Treatment of Erectile Dysfunction Y. Vardi, B. Appel, I Gruenwald Neuro-Urology Unit, Rambam Medical Center & the Technion Faculty of Medicine Haifa, Israel 3 crucial questions
More informationErectile dysfunction. By Anas Hindawi Supervised by Dr Khalid AL Sayyid
Erectile dysfunction By Anas Hindawi Supervised by Dr Khalid AL Sayyid ED is the persistent/recurrent inability to attain and/or maintain a penile erection rigid enough for satisfactory sexual intercourse
More informationEvidence Review for Surrey Prescribing Clinical Network. Treatment: Oral and non-oral combination therapy for erectile dysfunction
Evidence Review for Surrey Prescribing Clinical Network Treatment: Oral and non-oral combination therapy for erectile dysfunction Prepared by: Linda Honey Topic Submitted by: Prescribing Clinical Network
More informationErectile Dysfunction: A Primer for Primary Care Providers
Erectile Dysfunction: A Primer for Primary Care Providers Jeanne Martin, DNP, ANP-BC Objectives 1. Understand the definition, incidence and prevalence of Erectile Dysfunction in the U.S. 2. Understand
More informationGUIDELINES ON ERECTILE DYSFUNCTION
GUIDELINES ON ERECTILE DYSFUNCTION (Text updated March 2005) E. Wespes (chairman), E. Amar, D. Hatzichristou, K. Hatzimouratidis, F. Montorsi, J. Pryor, Y. Vardi 88 Erectile Dysfunction Eur Urol 2001;40:97-101
More informationOverview. Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia. Iain McAuley September 15, 2014
Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia Iain McAuley September 15, 2014 Overview Review of the most recent guidelines for ED and BPH ED Guidelines CUA 2006 AUA 2011
More informationGUIDELINES ON ERECTILE DYSFUNCTION
16 GUIDELINES ON ERECTILE DYSFUNCTION E. Wespes (chairman), E. Amar, D. Hatzichristou, Dr. F. Montorsi, J. Pryor, Y. Vardi Eur Urol 2002;41:1-5 1. Background, definition and classification Male erectile
More informationMALE SEXUAL DYSFUNCTION. Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara
MALE SEXUAL DYSFUNCTION Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara DEFINITION The inability to achieve a satisfactory sexual relationship May involve : - inadequacy
More informationOpinion: Yes. PDE-5 inhibitors should be used post radical prostatectomy as erection function rehabilitation?
Difference of opinion Vol. 43 (3): 385-389, May - June, 2017 doi: 10.1590/S1677-5538.IBJU.2017.03.03 PDE-5 inhibitors should be used post radical prostatectomy as erection function rehabilitation? Opinion:
More informationA NEW APPROACH FOR THE PATIENT WITH ERECTILE DYSFUNCTION
Promotional supplement A NEW APPROACH FOR THE PATIENT WITH ERECTILE DYSFUNCTION This symposium took place on 21 st March 2015 (18.00 19.30) as part of the Annual European Association of Urology (EAU) Congress
More informationIan Eardley Department of Urology, Leeds Teaching Hospital Trust
Ian Eardley Department of Urology, Leeds Teaching Hospital Trust Assessment of the man with ED Medical therapy for man with ED What to do when pills fail Sexual stimulus Neural pathways Neurotransmitter
More informationERECTILE DYSFUNCTION. Prof. Khan Abul Kalam Azad. Head, Department of Medicine, Dhaka Medical College President, Bangladesh Society of Medicine
ERECTILE DYSFUNCTION Prof. Khan Abul Kalam Azad Head, Department of Medicine, Dhaka Medical College President, Bangladesh Society of Medicine Bangladesh Society of Medicine Department of Medicine Dhaka
More informationErectile Dysfunction Medical Treatment
1 Erectile Dysfunction Medical Treatment Alireza Ghoreifi Assistant of Urology Mashhad University of Medical Sciences March 2012 2 Treatment of ED Unknown cases of ED First-line therapy Second-line therapy
More informationI N T I M A C Y A N D S E X U A L I T Y I N L A T E R L I F E
I N T I M A C Y A N D S E X U A L I T Y I N L A T E R L I F E 2 0 1 6 DESPITE THE COMMON COMPLAINT, EACH PATIENT COMES AS AN INDIVIDUAL, WITH UNIQUE EXPECTATIONS My special interest Counseling patients
More informationManaging Erectile Dysfunction
Managing Erectile Dysfunction Lewis E. Harpster MD, FACS Urology of Central PA 4/23/16 1 Objectives 1. Review physiologic mechanism of erection 2. Discuss medical management of ED 3. Discuss surgical management
More informationManaging the Patient with Erectile Dysfunction: What Would You Do?
Managing the Patient with Erectile Dysfunction: What Would You Do? Florida A & M University College of Pharmacy and Pharmaceutical Sciences 42 nd Annual Clinical Symposium Wayne A. Sampson, M.D. Cross
More informationED treatments: PDE5 inhibitors, injections and vacuum devices
ED treatments: PDE5 inhibitors, injections and vacuum devices Martin Steggall Clinical Nurse Specialist (Erectile Dysfunction and Premature Ejaculation) Barts Health NHS Trust; Associate Dean, Director
More informationErectile Dysfunction. written by Harvard Medical School.
Erectile Dysfunction written by Harvard Medical School www.patientedu.org Until treatment became widely available in the 1990s, erectile dysfunction (ED) was called impotence and few men faced up to the
More informationChristopher C.K. Ho. Consultant Urologist Oriental Melaka Medical Centre Adjunct Professor, Taylor s University
Christopher C.K. Ho MD, MS, MRCSEd, MBU, MFSTEd, AM, FICS, FECSM, FRCSEd, FRCS(Urol)(Glasg), FACS Consultant Urologist Oriental Melaka Medical Centre Adjunct Professor, Taylor s University Inability to
More informationUpdate on Erection Dysfunction. Seacourses Eastern Caribbean December 30, 2017 January 6, 2018 Stacy Elliott MD
Update on Erection Dysfunction Seacourses Eastern Caribbean December 30, 2017 January 6, 2018 Stacy Elliott MD Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced,
More informationInitial experience with linear focused shockwave treatment for erectile dysfunction: a 6-month follow-up pilot study
International Journal of Impotence Research (2014), 1 5 2014 Macmillan Publishers Limited All rights reserved 0955-9930/14 www.nature.com/ijir ORIGINAL ARTICLE Initial experience with linear focused shockwave
More informationDiagnosis and management of sexual dysfunction. Dr Chris Simpson Consultant Psychiatrist
Diagnosis and management of sexual dysfunction Dr Chris Simpson Consultant Psychiatrist What are we talking about? Male Erectile dysfunction Premature ejaculation Delayed ejaculation Sexual aversion Paraphilia
More informationavanafil 50mg, 100mg, 200mg tablets (Spedra ) SMC No. (980/14) A. Menarini Farmaceutica Internazionale SRL.
avanafil 50mg, 100mg, 200mg tablets (Spedra ) SMC No. (980/14) A. Menarini Farmaceutica Internazionale SRL. 07 August 2015 The Scottish Medicines Consortium (SMC) has completed its assessment of the above
More informationTreatment for ED. Education and couple assessment. Lifestyle advice. Patient Information. Page 1 / 9. Patient Information - Treatment for ED
Patient Information English 3 Treatment for ED The underlined terms are listed in the glossary. Erectile dysfunction (ED) is a common condition. Although it is not life threatening, it can negatively affect
More informationIs This Really a Fair Debate? 2013 MFMER slide-2
Sex Rehab after Radical Prostatectomy: Is it Really Justified? Con Position Landon Trost, MD Assistant Professor of Urology Mayo Clinic, Rochester, MN ISSM 16 th World Meeting on Sexual Medicine October
More informationPenile Implant Should be Offered Early
Penile Implant Should be Offered Early Landon Trost, MD Assistant Professor in Urology Mayo Clinic, Rochester, MN SMSNA AUA May 16 th, 2015 2013 MFMER slide-1 Clear Indications for Penile Implants Men
More informationfor ED and LUTS/BPH Pierre Sarkis, M.D. Assistant Professor Fellow of the European Board of Urology
Tadalafil 5 mg once daily for ED and LUTS/BPH Pierre Sarkis, M.D. Assistant Professor Fellow of the European Board of Urology Why this conference? Not promotional but educational The pharmacist regularly
More informationErectile Dysfunction Case Study 2. Medical Student Case-Based Learning
Erectile Dysfunction Case Study 2 Medical Student Case-Based Learning The Case of Mr. Power s Limp Mojo Mr. Powers develops erectile dysfunction after his radical prostatectomy for prostate cancer. You
More informationEfficacy and Safety of Linear Focused Shockwaves for Erectile Dysfunction (RENOVA) A Second Generation Technology
Efficacy and Safety of Linear Focused Shockwaves for Erectile Dysfunction (RENOVA) A Second Generation Technology Y. Reisman, MD, PhD. 1, A. Hind, MD. 2, A. Varaneckas, MD. 3, I. Motil, MD. 4 1 Men's Health
More informationEffects of Low-Intensity Extracorporeal Shockwave Therapy on Erectile Dysfunction: A Systematic Review and Meta-Analysis
REVIEW PAPERS Effects of Low-Intensity Extracorporeal Shockwave Therapy on Erectile Dysfunction: A Systematic Review and Meta-Analysis Raul I. Clavijo, MD, 1, * Taylor P. Kohn, MD, 2, * Jaden R. Kohn,
More informationTreatment for ED. Education and couple assessment. Lifestyle advice. Patient Information. Page 1 / 10. Patient Information - Treatment for ED
Patient Information English 3 Treatment for ED The underlined terms are listed in the glossary. Erectile dysfunction (ED) is a common condition. Although it is not life threatening, it can negatively affect
More informationGUIDELINES ON MALE SEXUAL DYSFUNCTION: Erectile Dysfunction and Premature Ejaculation
GUIDELINES ON MALE SEXUAL DYSFUNCTION: Erectile Dysfunction and Premature Ejaculation (Text update March 2009) E. Wespes, E. Amar, I. Eardley, F. Giuliano, D. Hatzichristou, K. Hatzimouratidis, F. Montorsi,
More informationPenile Rehabilitation after Radical Prostatectomy
Penile Rehabilitation after Radical Prostatectomy The PRO Position John P. Mulhall MD MSc FECSM FACS Director, Sexual & Reproductive Medicine Program Urology Service Memorial Sloan Kettering Cancer Center
More informationErectile Dysfunction Prior Authorization with Quantity Limit Criteria Program Summary
Prior Authorization with Quantity Limit Criteria Program Summary Objective The intent of the prior authorization (PA) program for (ED) is to ensure appropriate selection of patients for treatment according
More informationEAU Guidelines on Erectile Dysfunction, Premature Ejaculation, Penile Curvature and Priapism
EAU Guidelines on Erectile Dysfunction, Premature Ejaculation, Penile Curvature and Priapism K. Hatzimouratidis (Chair), F. Giuliano, I. Moncada, A. Muneer, A. Salonia (Vice-chair), P. Verze European Association
More informationDirect comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: a systematic review and meta analysis
Int Urol Nephrol (2017) 49:1731 1740 DOI 10.1007/s11255-017-1644-5 UROLOGY - ORIGINAL PAPER Direct comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: a systematic review
More informationERECTILE DYSFUNCTION PREMATURE EJACULATION. David Goldmeier
ERECTILE DYSFUNCTION PREMATURE EJACULATION David Goldmeier d.goldmeier@nhs.net LEARNING OBJECTIVES Management of erectile dysfunction and premature ejaculation in General Practice Discussion and consideration
More informationEAU Guidelines on Erectile Dysfunction, Premature Ejaculation, Penile Curvature and Priapism
EAU Guidelines on Erectile Dysfunction, Premature Ejaculation, Penile Curvature and Priapism K. Hatzimouratidis (Chair), F. Giuliano, I. Moncada, A. Muneer, A. Salonia (Vice-chair), P. Verze Guideline
More informationNew Medicine Assessment
New Medicine Assessment Alprostadil 3 milligram/gram cream (Vitaros ) Treatment of men 18 years of age with erectile dysfunction Recommendation: Alprostadil 3 mg/g cream is recommended as an alternative
More information/04/ /0 Reprinted from Vol. 172, , August 2004 THE JOURNAL OF UROLOGY
0022-5347/04/1722-0658/0 Reprinted from Vol. 172, 658 663, August 2004 THE JOURNAL OF UROLOGY Printed in U.S.A. Copyright 2004 by AMERICAN UROLOGICAL ASSOCIATION DOI: 10.1097/01.ju.0000132389.97804.d7
More informationTestosterone and PDE5 inhibitors in the aging male
Testosterone and PDE5 inhibitors in the aging male Francesco Romanelli Department of Experimental Medicine Medical Pathophysiology, Food Science and Endocrinology Section Sapienza University of Rome 3005
More informationJan Farrell. Nurse Consultant Urology Department of Urology Rotherham General Hospital NHS FT
Jan Farrell Nurse Consultant Urology Department of Urology Rotherham General Hospital NHS FT Aims of session To promote discussion / interaction Opportunity to discuss with peers Promote learning / share
More informationErectile dysfunction: unmet needs
Erectile dysfunction: unmet needs Dimitris Hatzichristou Professor of Urology / Andrology Director, Center for Sexual and Reproductive Health Aristotle University of Thessaloniki, Greece The numbers MMAS
More informationClinical efficacy and safety of Vitaros /Virirec (Alprostadil cream) for the treatment of erectile dysfunction
Urologia 2015 ; 82 ( 2): 84-92 DOI: 10.5301/uro.5000116 UISSN 0391-5603 DRUG REVIEW Clinical efficacy and safety of Vitaros /Virirec (Alprostadil cream) for the treatment of erectile dysfunction Ignacio
More informationXVII Congresso Regionale A.R.C.A Holiday Inn ROMA 22 settembre 2017 TREATMENT OF ERECTILE DYSFUNCTION: THE ROLE OF INTERVENTIONAL CARDIOLOGY
XVII Congresso Regionale A.R.C.A Holiday Inn ROMA 22 settembre 2017 TREATMENT OF ERECTILE DYSFUNCTION: THE ROLE OF INTERVENTIONAL CARDIOLOGY CONFLICTS OF FINANCIAL INTERESTS ERECTILE DYSFUNCTION IT S A
More informationErectile Dysfunction An overview. Lorraine Montgomery Specialist Nurse Practitioner Urology
Erectile Dysfunction An overview Lorraine Montgomery Specialist Nurse Practitioner Urology BAUN Essential Urology Study Day Centre for life: Newcastle. 20/9/2017 What is erectile dysfunction? The persistent
More informationClinical Trial Study Synopsis
Clinical Trial Study Synopsis This file is posted on the Bayer HealthCare Clinical Trials Registry and Results website and is provided for patients and healthcare professionals to increase the transparency
More informationSexuality and Bone Marrow Failure Diseases: A Conversation
Sexuality and Bone Marrow Failure Diseases: A Conversation Timothy Pearman, Ph.D. Director, Supportive Oncology Associate Professor Dept. of Medical Social Sciences Dept. of Psychiatry and Behavioral Sciences
More informationSEXUAL HEALTH. Erectile Dysfunction
SEXUAL HEALTH Erectile Dysfunction Don t Let Erectile Dysfunction Keep You from a Satisfying Sex Life. What Is Erectile Dysfunction or ED? Who Gets ED? Men who have ED have a problem getting or keeping
More informationDipartimento Ostetricia, Ginecologia, Urologia - Clinica Urologica Università di Napoli Federico II, Italy; 2
ORIGINAL PAPER DOI: 10.4081/aiua.2016.2.128 A survey on the experience of 136 Italian urologists in the treatment of erectile dysfunction with PDE5 inhibitors and recommendations for the use of Avanafil
More informationAssessment of Erectile and Ejaculatory Function after Penile Prosthesis Implantation
www.kjurology.org DOI:.4/kju.2.5.3.22 Sexual Dysfunction/Infertility Assessment of Erectile and Ejaculatory Function after Penile Prosthesis Implantation Jang Ho Bae, Phil Hyun Song, Hyun Tae Kim, Ki Hak
More informationORIGINAL INVESTIGATION. Sildenafil for Male Erectile Dysfunction
Sildenafil for Male Erectile Dysfunction A Systematic Review and Meta-analysis ORIGINAL INVESTIGATION Howard A. Fink, MD, MPH; Roderick Mac Donald, MS; Indulis R. Rutks, BS; David B. Nelson, PhD; Timothy
More informationClinical Trial Study Synopsis
Clinical Trial Study Synopsis This file is posted on the Bayer HealthCare Clinical Trials Registry and Results website and is provided for patients and healthcare professionals to increase the transparency
More informationA Proposed Study of Hyperbaric Oxygen Therapy Following Radical Prostatectomy: Effects on Erectile Dysfunction
A Proposed Study of Hyperbaric Oxygen Therapy Following Radical Prostatectomy: Effects on Erectile Dysfunction Anthony J. Bella MD, FRCSC Division of Urology, Department of Surgery and Department of Neuroscience
More information13-Oct-15 ERECTILE DYSFUNCTION. Urology Subdepartement dr. Mintohardjo Naval Hospital dr. Isdiyanto Septiadi, Sp.U
ERECTILE DYSFUNCTION Urology Subdepartement dr. Mintohardjo Naval Hospital dr. Isdiyanto Septiadi, Sp.U 1 2 3 So what is impotence or erectile dysfunction..? The persistent inability to achieve or maintain
More informationErectile dysfunction (ED) is a common male sexual. Clinical Guidelines
Clinical Guidelines Annals of Internal Medicine Oral Phosphodiesterase-5 Inhibitors and Hormonal Treatments for Erectile Dysfunction: A Systematic Review and Meta-analysis Alexander Tsertsvadze, MD, MSc;
More informationThe efficacy and safety of tadalafil: an update
Original Article C.C. CARSON et al. The efficacy and safety of tadalafil: an update C.C. CARSON, J. RAJFER, I. EARDLEY, S. CARRIER, J.S. DENNE, D.J. WALKER, W. SHEN and W.H. CORDELL Department of Surgery,
More informationCentral hemodynamics and prediction of cardiovascular events in patients with erectile dysfunction
Central hemodynamics and prediction of cardiovascular events in patients with erectile dysfunction N.Skliros, N.Ioakeimidis, D.Terentes-Printzios, C.Vlachopoulos Cardiovascular Diseases and Sexual Health
More informationMinimal Clinically Important Differences in the Erectile Function Domain of the International Index of Erectile Function Scale
EUROPEAN UROLOGY 60 (2011) 1010 1016 available at www.sciencedirect.com journal homepage: www.europeanurology.com Platinum Priority Sexual Medicine Editorial by Andrea Salonia on pp. 1017 1019 of this
More informationMMM. Topic The use of Tadalafil 5mg daily for the treatment of BPH-LUTS
Dr Tan & Partners MMM Vol. 1 No. 1 Morbidity & Mortality Meeting 14 th November 2014 Introduction Topic The use of Tadalafil 5mg daily for the treatment of BPH-LUTS Tadalafil 5mg daily is a well established
More informationJan Farrell Nurse Consultant Urological Services Department of Urology Rotherham General Hospital NHS FT
Jan Farrell Nurse Consultant Urological Services Department of Urology Rotherham General Hospital NHS FT Aims of session To promote discussion / interaction Opportunity to discuss with peers Promote learning
More information/02/ /0 Vol. 168, , October 2002 THE JOURNAL OF UROLOGY
0022-5347/02/1684-1332/0 Vol. 168, 1332 1336, October 2002 THE JOURNAL OF UROLOGY Printed in U.S.A. Copyright 2002 by AMERICAN UROLOGICAL ASSOCIATION, INC. DOI: 10.1097/01.ju.0000028041.27703.da Original
More informationGerald Brock Professor of Surgery University of Western Ontario
Treatment Induced Erectile Dysfunction Gerald Brock Professor of Surgery University of Western Ontario 1 1 2 Should you believe in Rehab? 3 3 Should you believe in Rehab? Avoidance Education related to
More informationDATE BIO# NAME: Last First Middle REFERRING PHYSICIAN NAME: REFERRING PHYSICIAN SPECIALTY (Urologist, Internist, etc.): PRIMARY CARE PHYSICIAN NAME:
DATE BIO# ERECTILE DYSFUNCTION QUESTIONNAIRE NAME: Last First Middle BIRTHDATE: OCCUPATION: REFERRING PHYSICIAN NAME: REFERRING PHYSICIAN SPECIALTY (Urologist, Internist, etc.): PRIMARY CARE PHYSICIAN
More informationaviptadil / phentolamine 25 micrograms / 2mg solution for injection (Invicorp ) SMC No 1284/17 Evolan Pharma AB
aviptadil / phentolamine 25 micrograms / 2mg solution for injection (Invicorp ) SMC No 1284/17 Evolan Pharma AB 10 November 2017 The Scottish Medicines Consortium (SMC) has completed its assessment of
More informationERECTILE DYSFUNCTION DIAGNOSIS
ERECTILE DYSFUNCTION DIAGNOSIS Head of Andrology and Sexual Medicine Dep.of Urology and Nefrology Hospital Virgen del Rocío ANDROMEDI. Sexual Medicine SEVILLA. SPAIN General Secretary ESSM Natalio Cruz
More informationClinical evaluation of Tentex forte and Himcolin cream in the treatment of functional erectile dysfunction
Medicine Update (2004): 11(9), 47-51 Clinical evaluation of Tentex forte and Himcolin cream in the treatment of functional erectile dysfunction Dr. Roumen Bostandjiev, Ph.D. Founder and Director of Sexology
More informationInformation for Patients. Erectile Dysfunction. English
Information for Patients Erectile Dysfunction English Table of contents What is ED?... 3 How common is ED?... 3 What causes ED?... 3 Cardiovascular disease and ED... 3 Urinary symptoms and ED... 3 Psychological
More informationClinical Commissioning Policy Proposition:
Clinical Commissioning Policy Proposition: Penile prosthesis surgery for end stage erectile dysfunction Version Number: NHS England B14X10/01 Information Reader Box (IRB) to be inserted on inside front
More informationTreatment Strategy for Non-Responders to PDE5 Inhibitors
pissn: 2287-4208 / eissn: 2287-4690 World J Mens Health 2013 April 31(1): 31-35 http://dx.doi.org/10.5534/wjmh.2013.31.1.31 Review Article Treatment Strategy for Non-Responders to PDE5 Inhibitors Nam Cheol
More informationShockwave Therapy Applications
Shockwave Pressure Level (bar) Shockwave Therapy Applications 500 Urology 250 0 ESWL ~ 450 Bar Stone Fragmentation ESWT ~ 200 bar Anti Inflammatory Orthopedics LSWT ~80 bar Angiogenesis ED 80 s 90 s 2000+
More informationThe Men s Clinic at UCLA
The Men s Clinic at UCLA Discretion, dignity and respect The Men s Clinic at UCLA is dedicated to male health and, in particular, to the treatment of conditions affecting men s urologic, sexual and reproductive
More information** REGULATORY ALERT **
Complete Summary GUIDELINE TITLE The management of erectile dysfunction: an update. BIBLIOGRAPHIC SOURCE(S) Erectile Dysfunction Guideline Update Panel. The management of erectile dysfunction: an update.
More informationNational Institute for Health and Care Excellence. Lower Urinary Tract Symptoms Update Addendum Consultation Table 3 rd February 5 pm 3 rd March 2015
British Association of Urological Surgeons British Association of Urological Surgeons National Institute for Health and Care Excellence Lower Urinary Tract Symptoms Update Addendum Consultation Table 3
More informationIntroduction. Domain (IIEF-EF domain) and Clinical Global Impression of Change (CGIC) scores at 1, 3, 6, 9 and 12 months posttreatment.
Low intensity extracorporeal shockwave therapy for erectile dysfunction: a study in an Indian population Vasan Satya Srini, MD, 1 Rahul Kumar Reddy, MD, 1 Tamar Shultz, PhD, 2 Bela Denes, MD 3 1 Department
More informationLSWT. Linear Shockwave Therapy for Erectile Dysfunction Clinical Data and Reports
LSWT Linear Shockwave Therapy for Erectile Dysfunction Clinical Data and Reports November 2015 Table of Contents Safety and efficacy of low intensity shockwave (LISW) treatment in patients with erectile
More informationErectile Dysfunction; It s Not Just About Sex
Erectile Dysfunction; It s Not Just About Sex Disclosures Conflict of interest: I am not paid by Boston Scientific but once in a while they buy me a tasty meal. I do routinely use their products without
More informationMedicines Q&As. Date prepared: November 2016
Q&A 128.3 What is the rationale and evidence for the use of phosphodiesterase-5 inhibitors as supportive therapy to rehabilitate Erectile Function after nerve sparing radical prostatectomy? Summary Prepared
More informationSexual Function/Infertility
Sexual Function/Infertility Does Low Intensity Extracorporeal Shock Wave Therapy Have a Physiological Effect on Erectile Function? Short-Term Results of a Randomized, Double-Blind, Sham Controlled Study
More informationMale Sexual Dysfunction:
Guidelines on Male Sexual Dysfunction: Erectile dysfunction and premature ejaculation E. Wespes, E. Amar, I. Eardley, F. Giuliano, D. Hatzichristou, K. Hatzimouratidis, F. Montorsi, Y. Vardi European Association
More information2018 Canadian Urological Association guideline for Peyronie s disease and congenital penile curvature
2018 Canadian Urological Association guideline for Peyronie s disease and congenital penile curvature Anthony J. Bella, Jay C. Lee, Ethan D. Grober, Serge Carrier, Francois Benard, Gerald B. Brock Originally
More informationERECTILE DYSFUNCTION. & Current Therapies. GP Conference, Rotorua 7-10 June 2012
ERECTILE DYSFUNCTION & Current Therapies GP Conference, Rotorua 7-10 June 2012 Jan Burns & Annie Woodsford Jan: EN, RCpN, BHSc, RPN (USA),MHSc, Member of the Sexual Medicine Society Urology Nurse Specialist
More informationAvanafil for the treatment of erectile dysfunction: initial data and clinical key properties
466282TAU511756287212466282Therapeutic Advances in UrologyGT Kedia, S Ückert 2012 Therapeutic Advances in Urology Review Avanafil for the treatment of erectile dysfunction: initial data and clinical key
More informationClinical Trial Study Synopsis
Clinical Trial Study Synopsis This file is posted on the Bayer HealthCare Clinical Trials Registry and Results website and is provided for patients and healthcare professionals to increase the transparency
More informationLONG-TERM EFFECT OF SILDENAFIL CITRATE ON ERECTILE DYSFUNCTION AFTER RADICAL PROSTATECTOMY: 3-YEAR FOLLOW-UP
ADULT UROLOGY LONG-TERM EFFECT OF SILDENAFIL CITRATE ON ERECTILE DYSFUNCTION AFTER RADICAL PROSTATECTOMY: 3-YEAR FOLLOW-UP RUPESH RAINA, MILTON M. LAKIN, ASHOK AGARWAL, RAKESH SHARMA, KUSH K. GOYAL, DROGO
More informationAcceptance of and Discontinuation Rate from Erectile Dysfunction Oral Treatment in Patients following Bilateral Nerve-Sparing Radical Prostatectomy
european urology 53 (2008) 564 570 available at www.sciencedirect.com journal homepage: www.europeanurology.com Prostate Cancer Acceptance of and Discontinuation Rate from Erectile Dysfunction Oral Treatment
More informationThe Investigation and Management of Erectile Dysfunction
Guideline for Administered by the Alberta Medical Association The Investigation and Management of Erectile Dysfunction 00 Update This clinical practice guideline replaces the Alberta Laboratory Endocrine
More informationGuidelines on Erectile Dysfunction
Guidelines on Erectile Dysfunction E. Wespes, E. Amar, D. Hatzichristou, K. Hatzimouratidis, F. Montorsi, J. Pryor, Y. Vardi European Association of Urology 2006 TABLE OF CONTENTS PAGE 1. BACKGROUND 4
More informationErectile Dysfunction (ED) Shawn McGee M.D. CentraCare Adult and Pediatric Urology January 30 th, 2016
Erectile Dysfunction (ED) Shawn McGee M.D. CentraCare Adult and Pediatric Urology January 30 th, 2016 Erectile dysfunction: The inability to attain or maintain penile erection sufficient for satisfactory
More informationWith My Heart, Can or Should I Take Erectile Dysfunction Drugs?
With My Heart, Can or Should I Take Erectile Dysfunction Drugs? Timothy R. Malinowski MD, FACC UMG Carolina Cardiology Consultants Greenville Health System Definition of Erectile Dysfunction 1992 NIH Consensus
More informationSexual problems in the ageing male: ED
Sexual problems in the ageing male: ED Prism IV September 25-26 Bruges, Belgium Dr. HHJ Leliefeld and Prof. FMJ Debruyne, urologists The Netherlands Erectile disfunction Definition & Prevalence The erectile
More informationSexual Health and Dysfunction in the Elderly. Nadya S. Dávila Lourido, MD September 28, 2018
Sexual Health and Dysfunction in the Elderly Nadya S. Dávila Lourido, MD September 28, 2018 Objectives: To review physiologic changes associated with aging To discuss the importance of the history and
More information